These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34248305)

  • 1. The Dilemma of Intellectual Property Agreements and R&D in Developing Economies: A Game Theory Approach.
    El-Aroui MA; Dellagi S; Abdelaziz FB
    J Quant Econ; 2021; 19(3):427-450. PubMed ID: 34248305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTELLECTUAL PROPERTY IN THE TWENTY-FIRST CENTURY: WILL THE DEVELOPING COUNTRIES LEAD OR FOLLOW?
    Reichman JH
    Houst Law Rev; 2009 Jan; 46(4):1115-1185. PubMed ID: 21423816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the effect of TRIPS on availability of priority vaccines.
    Milstien J; Kaddar M
    Bull World Health Organ; 2006 May; 84(5):360-5. PubMed ID: 16710544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel imports and innovation in an emerging economy: the case of Indian pharmaceuticals.
    Mantovani A; Naghavi A
    Health Econ; 2012 Nov; 21(11):1286-99. PubMed ID: 23027711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
    Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
    Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry.
    Billette de Villemeur E; Versaevel B
    J Health Econ; 2019 May; 65():260-283. PubMed ID: 31158785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The make or buy debate: considering the limitations of domestic production in Tanzania.
    Wilson KR; Kohler JC; Ovtcharenko N
    Global Health; 2012 Jun; 8():20. PubMed ID: 22747578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.
    Townsend B; Gleeson D; Lopert R
    Asia Pac J Public Health; 2016 Nov; 28(8):682-693. PubMed ID: 27920239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.
    Son KB; Lee TJ
    Glob Public Health; 2018 Sep; 13(9):1169-1178. PubMed ID: 28585477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
    Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
    Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globalization in the pharmaceutical industry, Part II.
    Casadio Tarabusi C; Vickery G
    Int J Health Serv; 1998; 28(2):281-303. PubMed ID: 9595345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
    Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
    Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promote or inhibit? The effect of the whole chain development of intellectual property on manufacturing firm performance.
    Yu L; Zhao C
    Front Psychol; 2023; 14():1100865. PubMed ID: 36910787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
    Adekola TA
    Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trade, TRIPS, and pharmaceuticals.
    Smith RD; Correa C; Oh C
    Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal Environment, Technological Innovation, and Sustainable Economic Growth.
    Zhao Y
    Front Psychol; 2022; 13():929359. PubMed ID: 35967692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual property and the commercialization of research and development.
    di Norcia V
    Sci Eng Ethics; 2005 Apr; 11(2):203-19. PubMed ID: 15915860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A typology of intellectual property management for public health innovation and access: design considerations for policymakers.
    Taubman A
    Open AIDS J; 2010 Jan; 4():4-24. PubMed ID: 20517487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.